Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
marketwatch.com
news
2022-05-31 21:27:00

Shares of Vertex Pharmaceuticals Inc. VRTX, -1.86% slid 1.86% to $268.65 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX, -0.63% falling 0.63% to 4,132.15 and Dow Jones Industrial Average DJIA, -0.67% falling 0.67% to 32,990.12. Vertex Pharmaceuticals Inc. closed $24.10 below its 52-week high ($292.75), which the company achieved on April 14th. The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, -0.
